Vitamin D3 for Life

Live Enlightened

Article

Vitamin D Signalling Across Metabolism, Immunity and Endocrine Context: Full Evidence Review

Previous related pageVitamin D in AdolescenceNext related pageVitamin D Signalling Across Metabolism, Immunity and Endocrine Context: Study Summary
Study at a glance

What did studies examine about vitamin D signals across different tissues?

The review examines how the amount of vitamin D available, its activation within tissues, its receptors and tissue responses relate to one another. It combines separate studies in kidneys, airways, skin, muscle and the intestine. These studies did not test one treatment that improved all these systems together.

How did hormones change vitamin D activity in mouse kidneys?

In mice, hormones changed the activity of genes involved in activating and inactivating vitamin D. The direction of a response could change with time. Drugs that blocked selected enzymes also changed kidney measurements and some hormone measurements in bone and blood. This supports feedback between organs, but the drugs did not reproduce every effect of the natural hormone.

Did vitamin D signals work the same way in every tissue?

Airway and skin cells could activate vitamin D locally and change selected defence responses, with differences between triggers and tissues. Muscle experiments separated responses to vitamin D compounds from effects of removing or greatly increasing the receptor. Intestinal studies linked receptor changes with barrier measurements, microbes and their products. These findings did not establish one complete chain from supplements to better health.

Do changes in vitamin D signals guarantee better health?

A blood vitamin D level, active hormone near a cell, receptor activity and useful tissue function are different measurements. A change in one does not guarantee a beneficial change in the others. Timing, cell type and the intervention matter. Some proposed links were not tested by selectively interrupting them. The evidence supports control of vitamin D responses that differs between tissues, but does not establish a general clinical benefit from supplementation or an individual treatment plan.

Read the full article below ↓

Vitamin D signalling links hormone availability with tissue responses. Local airway, skin, muscle and gut experiments reveal distinct mechanisms; a renal hormone study adds direct evidence of endocrine feedback across kidney, bone and circulation. Their combination supports a conditional physiological model. For the companion appraisal, see Vitamin D Signalling Across Metabolism, Immunity and Endocrine Context: Study Summary.

Define the levels before connecting them

A circulating precursor, a locally generated active hormone, a receptor and a measured tissue response are different parts of the system. A blood concentration describes one aspect of exposure. Enzyme activity helps determine local availability. Receptor and cofactor function influence how a cell responds. Functional outcomes require their own measurements.

The local studies were not a single experiment measuring immune, metabolic and endocrine benefits together. A separate study by Meyer and colleagues examined regulation of the kidney enzymes Cyp27b1 and Cyp24a1 by parathyroid hormone, active vitamin D and fibroblast growth factor 23. This supplies an actual endocrine comparison within Vitamin D and Endocrine Crosstalk, while leaving the cross-tissue synthesis as an interpretation.

Renal hormone responses operate on different timescales

Meyer’s experiments used young adult mice and renal tissue measurements. Cyp27b1 participates in activation of the vitamin D precursor, whereas Cyp24a1 participates in its inactivation pathway. The investigators combined time-resolved messenger RNA measurements with chromatin assays identifying where regulatory proteins were associated with DNA. These techniques interrogate different stages of regulation.

After parathyroid hormone, Cyp27b1 expression increased at about one hour. Cyp24a1 initially decreased, then increased at a later time point. Calcitriol and fibroblast growth factor 23, abbreviated FGF23, instead suppressed Cyp27b1 and increased Cyp24a1 in the reported time courses. A single sample could therefore miss or reverse the apparent direction of an evolving response.

The calcitriol and FGF23 expression time courses incorporated previously published data, while the study added regulatory-occupancy analyses. They should not be counted as independent replications simply because the curves appear in a later paper. Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1) provides the metabolic context; enzyme transcripts alone do not quantify the net circulating hormone concentration.

Regulatory occupancy supports a qualified molecular model

At the Cyp27b1 M1 regulatory region, parathyroid hormone rapidly increased association of phosphorylated CREB and the coactivators CBP and CRTC2. The clearest early responses occurred within fifteen to thirty minutes. Histone-acetylation and RNA-polymerase measurements added evidence about the surrounding transcriptional state. The proposed connection is that an endocrine signal changes the regulatory environment before the later enzyme-expression response.

Calcitriol increased VDR binding at Cyp27b1-associated regulatory regions, while RXR was already present and changed less at several sites. At Cyp24a1, both receptor components showed increased association in the reported comparisons. Receptor occupancy therefore cannot be interpreted as one uniform switch with an identical direction of gene regulation at every locus.

Chromatin immunoprecipitation identifies association in sampled tissue; it does not prove that all detected factors occupy one physical complex in every cell. The authors did not selectively remove CRTC2 to establish that its recruitment was necessary for every response. Biological replicate counts varied by experiment, and some reported peaks were less convincing than the M1 comparison. The evidence is strongest for specified regions and time points, not every arrow in the proposed model.

Kinase inhibition reveals endocrine feedback and differences

The investigators also inhibited salt-inducible kinases, abbreviated SIKs, using YKL-05-099 and SK-124. Both increased renal Cyp27b1, generally less than parathyroid hormone. Their Cyp24a1 responses were not identical: SK-124 did not produce the same clearly significant three-hour response seen with the other inhibitor. These compounds should not be described as interchangeable copies of the hormone.

Both inhibitors increased Fgf23 expression in vertebral tissue and circulating intact FGF23. YKL-05-099 also increased circulating parathyroid hormone at early time points, whereas the tested 40 mg/kg SK-124 regimen did not show that pattern. These measured bone and blood responses make the experiment relevant to feedback between organs, rather than solely a response inside an isolated kidney cell.

The combined-hormone experiments examined regulatory occupancy under additional conditions. They did not directly measure corresponding combined-treatment expression responses because the separate hormones reached their expression maxima at different times. It would therefore be an overstatement to infer functional dominance of one hormone from binding measurements alone. The study did not establish a human benefit from manipulating these kinases or vitamin D availability.

Airway and skin connect local metabolism with defence

Hansdottir and colleagues linked precursor conversion in primary airway epithelial cells with changes in defence-related genes and proteins. Schauber and colleagues examined injury-related activation and immune responses in skin. Both studies support a role for local metabolic context, while using different cells, stimuli and experimental tests.

Their differences are scientifically useful. Airway responses to viral stimuli did not imply the same behaviour towards the tested TLR2 ligands. Skin experiments showed a different relationship with TLR2-associated stimulation. A shared vitamin D pathway can therefore participate in different regulatory circuits without producing a uniform immune programme.

The full cellular comparisons are developed in Local Vitamin D Activation, Airway Defence and Epithelial Integrity: Full Evidence Review and Skin Vitamin D Synthesis, Local Activation and Signalling: Full Evidence Review. In the skin account, CD14 is a microbial-recognition coreceptor. Its role differs from the nuclear regulatory proteins measured in the renal chromatin experiments. Keeping those roles distinct prevents a shared word such as “cofactor” from implying an untested mechanism.

Muscle separates responsiveness from protein and tissue outcomes

The muscle-cell metabolism study found receptor-related transcriptional responses without consistent hypertrophy or activation of the measured Akt/S6 endpoints. The muscle-specific deletion study connected loss of VDR with changes in structure and performance in mice. These designs support different claims: responsiveness to exposure and the consequences of removing a receptor.

They cannot be joined into a proven sequence in which more precursor necessarily produces more muscle. The ligand-exposure experiment and genetic experiment differ in timing, developmental context and endpoints. An integrated explanation must retain those differences rather than treating them as successive steps measured in one system.

The detailed account, Vitamin D Receptors, Muscle Protein Synthesis and Adaptation: Full Evidence Review, also distinguishes the ligand-exposure experiments from later receptor-overexpression and protein-synthesis studies. Vitamin D and Protein Metabolism concerns a downstream process that cannot be inferred from one transcript. Likewise, Muscle VDR Deletion, Fibre Structure and Strength in Mice: Full Study separates genetic muscle effects from the human balance comparison.

Gut experiments suggest feedback without establishing a clinical chain

Li and colleagues linked vitamin D-related perturbations with Notch-associated signalling, junction organisation and tracer permeability in mouse colitis and epithelial models. Chatterjee and colleagues found tissue-, sex: and diet-dependent differences in faecal metabolites and microbial measurements after conditional VDR deletion. Together they connect host signalling with barrier and metabolic observations, without demonstrating one complete bidirectional feedback circuit.

The combined interpretation does not establish that a supplement will create a particular microbiome in people. Nor do faecal metabolite changes quantify circulating exposure or establish a systemic anti-inflammatory effect. The strongest causal evidence remains attached to the specific genetic and experimental comparisons.

The broader evidence review, Intestinal VDR, Barrier Function and Microbial Metabolism: Full Evidence Review, distinguishes junction and metabolite measurements from direct renewal, permeability and human intervention results. The Notch comparison supports partial pathway dependence, while the metabolomics study leaves mediation and circulating consequences unresolved. Establishing that a microbial product carries a particular disease effect would require selective interruption and restoration of that path.

Receptor presence and compartment are not outcome guarantees

The context in Vitamin D Receptors explains why a competent receptor is part of a response rather than a sufficient prediction of it. The renal occupancy results and the different airway and skin responses support that conditional view. Vitamin D and Gene Expression likewise distinguishes an associated regulatory protein, a transcript and a functional product.

An active metabolite measured in culture medium, a receptor measured in a tissue extract and a circulating precursor concentration describe different compartments. The amount in medium reflects production, removal and exchange during a specified interval. A tissue extract can contain several cell types. A blood concentration integrates multiple organs and exposures. None is a substitute for every other measurement.

Timing adds a second distinction. A rapid phosphorylation response, a later transcriptional response and a developmental phenotype can be related without being simultaneous or mechanistically equivalent. A receptor deletion present during development may change the starting structure of a tissue long before its final performance is measured. An acute exposure experiment instead asks what an already formed cell system does over a short interval.

Vitamin D Activation is therefore a control point, not a guarantee of a beneficial endpoint. A rise in active hormone in one compartment might accompany increased inactivation elsewhere. The renal studies show why feedback needs explicit timing, tissue and molecular measurements rather than a general assumption that all vitamin D-related changes point in the same direction.

What the integrated account can and cannot predict

The same cytokine or kinase can participate in several tissues and have different consequences depending on the cells involved and the timing of the response. A decrease in one inflammatory marker is not automatically beneficial in every setting; host defence also depends on appropriately timed recruitment and activation. Likewise, a change in muscle-related transcription does not specify force generation or resistance to fatigue.

The immune experiments are relevant to Vitamin D and Immune Modulation and Vitamin D and Inflammatory Signalling. They do not convert renal endocrine feedback into proof of a systemic anti-inflammatory treatment. Shared molecules make a connection plausible; matched interventions and outcomes are needed to establish its clinical consequence.

A useful integrated model distinguishes three kinds of connection. A biochemical conversion relates one molecular species to another. A receptor-dependent response relates an exposure to a cellular measurement. An outcome relationship connects the intervention with a tissue or clinical endpoint. Evidence for the first connection does not automatically quantify the second or establish the third.

This distinction makes the model useful for designing experiments. If a precursor fails to produce a response while directly supplied active hormone succeeds, conversion or availability becomes a candidate limiting step. If both exposures fail, receptor responsiveness, downstream machinery and the chosen endpoint need attention. If a cellular response occurs without a functional change, the response may be insufficient, compensated or unrelated to the outcome. These alternatives require different tests. A synthesis should preserve them instead of presenting every plausible connection as an established beneficial pathway.

A useful next test would specify which connection carries the proposed effect. Supplying active hormone can test a conversion limitation, while restoring a deleted receptor tests response capacity. A selective coactivator perturbation asks whether a regulatory interaction is necessary. A clinical intervention must then measure the intended clinical outcome. These are different tests, and a positive result in one cannot substitute for all the others.

Conclusion

The evidence supports tissue-dependent connections among vitamin D metabolism, local immune responses, cellular maintenance and endocrine feedback. The renal study directly links hormonal interventions with enzyme regulation and selected bone and circulating responses. Across the wider evidence, timing, compartment and intervention determine the interpretation; a unified clinical benefit from supplementation remains unestablished.

Sources and publication details

Respiratory Epithelial Cells Convert Inactive Vitamin D to its Active Form: Potential Effects on Host Defense. Hansdottir S and colleagues. Journal of Immunology. 2008;181:7090 to 7099. DOI: 10.4049/jimmunol.181.10.7090. PMID: 18981129.

Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Schauber J and colleagues. Journal of Clinical Investigation. 2007;117:803 to 811. DOI: 10.1172/JCI30142. PMID: 17290304.

Effects of 1,25(OH)2D3 and 25(OH)D3 on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy. van der Meijden K. and colleagues. Journal of Cellular Physiology. 2016;231(11):2517-2528. DOI: 10.1002/jcp.25388. PMID: 27018098.

Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway. Li Y and colleagues. Frontiers in Pharmacology. 2024;15:1421577. DOI: 10.3389/fphar.2024.1421577. PMID: 39130644.

Vitamin D receptor promotes healthy microbial metabolites and microbiome. Chatterjee I and colleagues. Scientific Reports. 2020;10:7340. DOI: 10.1038/s41598-020-64226-7. PMID: 32355205.

Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function. Girgis CM and colleagues. Journal of Cachexia, Sarcopenia and Muscle. 2019;10(6):1228 to 1240. DOI: 10.1002/jcsm.12460. PMID: 31225722.

Rapid genomic changes by mineralotropic hormones and kinase SIK inhibition drive coordinated renal Cyp27b1 and Cyp24a1 expression via CREB modules. Meyer MB and colleagues. Journal of Biological Chemistry. 2022;298(11):102559. DOI: 10.1016/j.jbc.2022.102559. PMID: 36183832.

Related reading

Original sources

Source

Rapid genomic changes by mineralotropic hormones and kinase SIK inhibition drive coordinated renal Cyp27b1 and Cyp24a1 expression via CREB modules

Published in Meyer MB and colleagues. Journal of Biological Chemistry (2022).

Publication details

Rapid genomic changes by mineralotropic hormones and kinase SIK inhibition drive coordinated renal Cyp27b1 and Cyp24a1 expression via CREB modules. Meyer MB and colleagues. Journal of Biological Chemistry. 2022;298(11):102559. DOI: 10.1016/j.jbc.2022.102559. PMID: 36183832.

Read more →